Madrigal Pharmaceuticals, Inc. · NASDAQ:MDGL
Levy Richard S sold 5,682 Madrigal Pharmaceuticals, Inc. shares (Form 4)
Traded May 22, 2026 · Filed May 22, 2026
On May 22, 2026, Levy Richard S (Director) sold 5,682 Madrigal Pharmaceuticals, Inc. shares at an average US$515.44 for US$2.93M under a trading plan, leaving 22,015 shares. Filed May 22, 2026 (Form 4).
- Sold
- 5,682 shares
- Price
- US$515.44 average (US$506.68 to US$519.98)
- Value
- US$2.93M
- Holding after
- 22,015 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 22, 2026 | Common Stock | Sale | 40 | US$506.68 | 27,657 | Direct |
| May 22, 2026 | Common Stock | Sale | 320 | US$508.24 | 27,337 | Direct |
| May 22, 2026 | Common Stock | Sale | 151 | US$510.36 | 27,186 | Direct |
| May 22, 2026 | Common Stock | Sale | 610 | US$511.40 | 26,576 | Direct |
| May 22, 2026 | Common Stock | Sale | 439 | US$512.50 | 26,137 | Direct |
| May 22, 2026 | Common Stock | Sale | 40 | US$512.97 | 26,097 | Direct |
| May 22, 2026 | Common Stock | Sale | 343 | US$514.67 | 25,754 | Direct |
| May 22, 2026 | Common Stock | Sale | 657 | US$515.92 | 25,097 | Direct |
| May 22, 2026 | Common Stock | Sale | 723 | US$516.87 | 24,374 | Direct |
| May 22, 2026 | Common Stock | Sale | 1,497 | US$517.59 | 22,877 | Direct |
| May 22, 2026 | Common Stock | Sale | 782 | US$518.76 | 22,095 | Direct |
| May 22, 2026 | Common Stock | Sale | 80 | US$519.98 | 22,015 | Direct |
Source
Related
- Madrigal Pharmaceuticals, Inc.
- Levy Richard S
- Madrigal Pharmaceuticals, Inc. shareholders
- Form 4 · Levy Richard S · Jun 18, 2026
- Form 4 · Sibold William John · Sep 11, 2026
- Form 4 · Kelley Shannon T · Aug 20, 2026
- Form 4 · Reed John C · Aug 18, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 29, 2026
- Form 4 · Sibold William John · Jul 20, 2026